Kaiser Permanente

Kaiser Permanente is a nonprofit healthcare organization that provides a comprehensive range of services, including preventive care, emergency care, hospital and medical services, as well as pharmacy services. Founded in 1945 and headquartered in Oakland, California, Kaiser Permanente has a strong presence in several states, including California, Colorado, Georgia, Hawaii, Ohio, Oregon, Washington, and the District of Columbia. The organization operates through a model that emphasizes integrated care, focusing on the overall health and well-being of its members. Additionally, Kaiser Permanente Ventures, established in 1997, serves as the venture capital arm of the organization, investing in innovative healthcare companies. The firm primarily targets investments in healthcare services, medical devices, diagnostics, health information technology, and biotechnology, focusing on companies based in the United States with substantial market potential. Through these initiatives, Kaiser Permanente aims to influence the future of healthcare delivery while supporting advancements within the industry.

118 past transactions

Kate Farms

Series C in 2022
Kate Farms specializes in the production of plant-based shakes and formulas for tube-fed adults and children. It develops a formula using organic, plant-based ingredients without the synthetic ingredients and common allergens found in traditional formulas. Kate Farms serves thousands of patients suffering from severe, chronic diseases to less serious medical issues, and is available through prescription and over-the-counter.

Incredible Health

Series B in 2022
Incredible Health is a career marketplace technology that connects health systems with nurses. Its mission is to help healthcare professionals live better lives and find and do the work. The AI technology custom matches the health system’s nurse hiring needs with experienced, permanent nurse talent for the hard-to-fill roles.

Ordr

Series C in 2022
Ordr makes it easy to secure every connected device, from traditional IT devices to newer and more vulnerable IoT, IoMT, and OT. Ordr uses deep packet inspection and advanced machine learning to discover every device, profile its risk and behavior, map all communications and protect it with automated policies. Organizations worldwide trust Ordr to provide real-time asset inventory, address risk and compliance and accelerate IT initiatives. Ordr is backed by top investors including Battery Ventures, Wing, and TenEleven Ventures.

Tidelift

Series C in 2022
Tidelift makes open source work better—for everyone. Through the Tidelift Subscription and in direct partnership with maintainers, Tidelift is a single source for proactively managed open source components and professional assurances around those components. Tidelift makes it possible for open source projects to thrive, so we can all create even more incredible software, even faster.

IntelyCare

Series C in 2022
IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

Osso VR

Series C in 2022
Osso VR is a surgical training and assessment platform that uses advanced virtual reality to train and assess medical personnel. Their product offers realistic hand-based interactions in an immersive training environment containing cutting-edge procedures and devices.

AnyRoad

Series B in 2022
AnyRoad is the market leader in Experiential Marketing. AnyRoad’s industry-leading platform enables businesses to operate and optimize their events, tours, classes, and activations to grow consumer brand loyalty and drive greater ROI.

DexCare

Series B in 2022
DexCare is a provider of platform-as-a-service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform them into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

NOCD

Series B in 2021
NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better. With NOCD, users can have face-to-face video therapy sessions with licensed therapists that specialize in OCD, as well as get 24/7 support between sessions from self-help tools and peer communities.

Genome Medical

Series C in 2021
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Osso VR

Series B in 2021
Osso VR is a surgical training and assessment platform that uses advanced virtual reality to train and assess medical personnel. Their product offers realistic hand-based interactions in an immersive training environment containing cutting-edge procedures and devices.

Protenus

Series D in 2021
Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. We are committed to innovation, determined to reduce risk, and focused on supporting our community of employees, customers, and ultimately, patients. Empowering healthcare to eliminate risk is at the heart of all we do. Founded in 2014, Protenus is a three-time winner of Forbes’ America’s Best Startup Employers, is a Great Place to Work®-Certified company, and was named one of 2021 CBInsights Digital Health 150, one of The Best Places to Work in Healthcare by Modern Healthcare, and one of the Best Places to Work in Baltimore by the Baltimore Business Journal and the Baltimore Sun. Learn more at Protenus.com and follow us on Twitter @Protenus.

PathAI

Series C in 2021
PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. PathAI is developing technology that assists pathologists in making accurate diagnoses for every patient, every time. The company was founded in 2016 and is based in Boston, Massachusetts.

Medically Home

Corporate Round in 2021
Medically Home is a tech-enabled clinical enterprise that provides all the necessary capabilities to safely-shift medical care from hospitals to patients’ homes. Its platform offers a virtual hospital program that connects patients with caregivers and supports the monitoring of, and communication with patients with high acuity illness that help patients and their families to access a medical command center that provides centralized, on-demand acute medical care management from the comfort of their homes. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Groups Recover Together

Series C in 2021
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

Vesta Healthcare

Venture Round in 2021
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

DexCare

Series A in 2021
DexCare is a provider of platform-as-a-service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform them into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

Evidation Health

Series E in 2021
Evidation measures health in everyday life and enables anyone to participate in groundbreaking research and health programs. Built upon a foundation of user privacy and control over permissioned health data, Evidation's Achievement platform is trusted by millions of individuals—generating data with unprecedented speed, scale, and rigor. We partner with leading healthcare companies to understand health and disease outside the clinic walls. Guided by our mission to enable and empower everyone to participate in better health outcomes, Evidation is working to bring people individualized, proactive, and accessible healthcare—faster. Founded in 2012, Evidation Heath is headquartered in California. We collaborate as a distributed team with additional offices around the globe. To learn more, visit evidation.com, or follow us on Twitter @evidation

Nuvolo

Series C in 2021
Nuvolo is an EAM platform that delivers a simple, intuitive, and user-friendly online and offline mobile experience. It is revolutionizing enterprise asset management by innovating on ServiceNow, an enterprise cloud platform. The company’s vision is to be the global leader in cloud-based EAM, powered by a culture of innovation and a relentless commitment to customer service. Fully optimized for growing, mobile workforces worldwide, Nuvolo delivers a simple, intuitive, and user-friendly online and offline mobile experience. It was founded in 2013 and is headquartered in Paramus, New Jersey with offices throughout the U.S. and internationally in London and Pune, India.

K Health

Series E in 2021
K Health, Inc. is a digital health company that offers a mobile application designed to provide personalized, data-driven health information and remote treatment options for a variety of conditions, including back and neck pain, allergies, and chronic illnesses. Founded in 2016 and headquartered in New York with an additional office in Israel, K Health leverages advanced machine learning techniques to analyze clinical health data, enabling users to better manage their health. The platform allows patients to understand how doctors diagnose and treat similar symptoms, facilitating access to quality care at a lower cost. Users can chat with healthcare professionals for less than traditional copays and maintain a history of their medical records, thereby empowering them with insights into their health management. K Health is supported by various prominent investors, reflecting its innovative approach to digital primary care.

New Amsterdam Pharma

Series A in 2021
NewAmsterdam Pharma is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

dMed

Series C in 2020
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.

Kate Farms

Series B in 2020
Kate Farms specializes in the production of plant-based shakes and formulas for tube-fed adults and children. It develops a formula using organic, plant-based ingredients without the synthetic ingredients and common allergens found in traditional formulas. Kate Farms serves thousands of patients suffering from severe, chronic diseases to less serious medical issues, and is available through prescription and over-the-counter.

Osso VR

Series A in 2020
Osso VR is a surgical training and assessment platform that uses advanced virtual reality to train and assess medical personnel. Their product offers realistic hand-based interactions in an immersive training environment containing cutting-edge procedures and devices.

Truepill

Series C in 2020
Truepill is a B2B pharmacy fulfillment service. They provide a pharmacy API and fulfillment of medications to 50 states from their own facilities. They work directly with D2C consumer brands (e.g. Hims, Nurx), digital health companies, and other healthcare organizations. They are a team of 150 employees and have raised funding from Initialized Capital, Y Combinator, Slow Ventures, Sound Ventures, Tuesday Capital, Foundation Capital, Index Ventures, Social Capital, Box Group, Joe Montana, and others. Founded in 2016 by Umar Afridi and Sid Viswanathan, Truepill is headquartered in San Mateo, California.

Ginger

Series D in 2020
Ginger is a telemental health provider delivering evidence-based behavioral health coaching, therapy, and psychiatry from a smartphone. Ginger's on-demand system brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone. The app provides members with access to the support they need within seconds, 24/7, 365 days a year. Millions of people have access to Ginger through leading employers, health plans, and its network of partners.

Genome Medical

Series B in 2020
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.

Cedar

Series C in 2020
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and headquartered in New York, United States.

Big Health

Series B in 2020
Big Health is a digital therapeutics company that operates a digital healthcare portal to offer fully-automated and highly personalized digital therapeutics and behavioral programs for mental health issues. Its portal offers an online personalized medicine-care and prepares a sleep improvement program in consultation with medical professionals that enable individuals to overcome their sleep-related disorders in an efficient manner.

Ordr

Series B in 2020
Ordr makes it easy to secure every connected device, from traditional IT devices to newer and more vulnerable IoT, IoMT, and OT. Ordr uses deep packet inspection and advanced machine learning to discover every device, profile its risk and behavior, map all communications and protect it with automated policies. Organizations worldwide trust Ordr to provide real-time asset inventory, address risk and compliance and accelerate IT initiatives. Ordr is backed by top investors including Battery Ventures, Wing, and TenEleven Ventures.

IntelyCare

Series B in 2020
IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

Vesta Healthcare

Series A in 2020
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Ginger

Series C in 2019
Ginger is a telemental health provider delivering evidence-based behavioral health coaching, therapy, and psychiatry from a smartphone. Ginger's on-demand system brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone. The app provides members with access to the support they need within seconds, 24/7, 365 days a year. Millions of people have access to Ginger through leading employers, health plans, and its network of partners.

Protenus

Series C in 2019
Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. We are committed to innovation, determined to reduce risk, and focused on supporting our community of employees, customers, and ultimately, patients. Empowering healthcare to eliminate risk is at the heart of all we do. Founded in 2014, Protenus is a three-time winner of Forbes’ America’s Best Startup Employers, is a Great Place to Work®-Certified company, and was named one of 2021 CBInsights Digital Health 150, one of The Best Places to Work in Healthcare by Modern Healthcare, and one of the Best Places to Work in Baltimore by the Baltimore Business Journal and the Baltimore Sun. Learn more at Protenus.com and follow us on Twitter @Protenus.

Freenome

Series B in 2019
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention.

Nuvolo

Series B in 2019
Nuvolo is an EAM platform that delivers a simple, intuitive, and user-friendly online and offline mobile experience. It is revolutionizing enterprise asset management by innovating on ServiceNow, an enterprise cloud platform. The company’s vision is to be the global leader in cloud-based EAM, powered by a culture of innovation and a relentless commitment to customer service. Fully optimized for growing, mobile workforces worldwide, Nuvolo delivers a simple, intuitive, and user-friendly online and offline mobile experience. It was founded in 2013 and is headquartered in Paramus, New Jersey with offices throughout the U.S. and internationally in London and Pune, India.

Omada

Series D in 2019
Omada Health is a digital care company that offers innovative and clinically effective digital health programs to empower individuals to engage in their health and lead healthier lives. The program is personalized to meet each participant’s unique needs as they evolve, ranging from diabetes prevention, type 2 diabetes management, hypertension, behavioral health, and musculoskeletal issues. Omada combines professional health coaching, connected health devices, real-time data, and personalized feedback to deliver clinically meaningful results. The company is the largest CDC-recognized provider of the National Diabetes Prevention Program.

Health Catalyst

Series F in 2019
Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical.

Health Catalyst

Debt Financing in 2019
Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical.

Vesta Healthcare

Series A in 2018
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Multisensor Diagnostics

Seed Round in 2018
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients.

CareAcademy

Seed Round in 2018
CareAcademy creates online training that empowers senior care professionals to deliver the highest caliber of service and improve the lives of older adults. More than 250,000 direct care workers are learning and growing professionally through CareAcademy. Coupled with its advanced reporting, training, and compliance management dashboard, CareAcademy is an end-to-end, scalable training solution that transforms home care businesses into efficient industry leaders.

Protenus

Series B in 2018
Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. We are committed to innovation, determined to reduce risk, and focused on supporting our community of employees, customers, and ultimately, patients. Empowering healthcare to eliminate risk is at the heart of all we do. Founded in 2014, Protenus is a three-time winner of Forbes’ America’s Best Startup Employers, is a Great Place to Work®-Certified company, and was named one of 2021 CBInsights Digital Health 150, one of The Best Places to Work in Healthcare by Modern Healthcare, and one of the Best Places to Work in Baltimore by the Baltimore Business Journal and the Baltimore Sun. Learn more at Protenus.com and follow us on Twitter @Protenus.

Genome Medical

Series A in 2018
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.
Collective Medical empowers care teams to improve patient outcomes by closing the communication gaps that undermine patient care. With a nationwide network engaged with every national health plan in the country, hundreds of hospitals and health systems and tens of thousands of providers, Collective’s system-agnostic platform is trusted by care teams to identify at-risk and complex patients and facilitate actionable collaboration to make better care decisions and improve outcomes. Based in Salt Lake City, Collective is proven to streamline transitions of care, improve coordination across diverse care teams, and reduce medically unnecessary hospital admissions.

Protenus

Series A in 2017
Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. We are committed to innovation, determined to reduce risk, and focused on supporting our community of employees, customers, and ultimately, patients. Empowering healthcare to eliminate risk is at the heart of all we do. Founded in 2014, Protenus is a three-time winner of Forbes’ America’s Best Startup Employers, is a Great Place to Work®-Certified company, and was named one of 2021 CBInsights Digital Health 150, one of The Best Places to Work in Healthcare by Modern Healthcare, and one of the Best Places to Work in Baltimore by the Baltimore Business Journal and the Baltimore Sun. Learn more at Protenus.com and follow us on Twitter @Protenus.

Chrono Therapeutics

Series B in 2016
Chrono Therapeutics (CHRONO) is a pharmaceutical company founded in 2004 with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) that offers real-time behavioral support. Chrono’s executive leadership combines years of professional experience and personal passions for developing life-saving medical products. Steeped with years of experience in product development, science, R&D an understanding of the consumer smoking cessation market, FDA approval experience and bringing life-saving products to market, the team represents a wide-array of knowledge that combined can help address the serious epidemic of smoking.

Big Health

Series B in 2016
Big Health is a digital therapeutics company that operates a digital healthcare portal to offer fully-automated and highly personalized digital therapeutics and behavioral programs for mental health issues. Its portal offers an online personalized medicine-care and prepares a sleep improvement program in consultation with medical professionals that enable individuals to overcome their sleep-related disorders in an efficient manner.

Bluesight

Series C in 2016
Bluesight solves supply chain inefficiencies and reduces risk by providing actionable analytics for every step of the medication lifecycle. Through the company's suite of Medication Intelligence solutions, Bluesight brings simplicity, visibility, and predictability to the complex of medication management.

CareGuardian

Series B in 2016
Careguardian was founded in 2014 with the vision of building a world where all caregivers are visible, recognized, and empowered. We recognized that delivering exceptional care and support for families started with reimagining how professional Caregivers are trained, supported, and connected. We extend that support to family caregivers as well, who play a vital role in ensuring older adults are able to age safely.

Vapotherm

Series C in 2015
Vapotherm is specializing in the development, manufacture, and marketing of respiratory devices that improve clinical outcomes, reduce overall delivery costs, and improve quality of life for patients. The company's breakthrough technology centers on the benefits of high flow delivery of breathing gases through a patented process for heating and humidification. Vapotherm high velocity therapy has been shown to provide proven, comfortable respiratory support without the use of a mask. High Velocity Therapy is a method of rethinking ventilatory support while keeping patient comfort and compliance in mind.

Validic

Series B in 2015
Validic is a technology platform that offers digital health and remote care programs for healthcare organizations. It connects to over 400 in-home clinical and mobile health devices and applications. The company's mission is to improve the quality of human life by building technology that makes personal data actionable.

Health Catalyst

Series D in 2015
Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical.

Bluesight

Series B in 2015
Bluesight solves supply chain inefficiencies and reduces risk by providing actionable analytics for every step of the medication lifecycle. Through the company's suite of Medication Intelligence solutions, Bluesight brings simplicity, visibility, and predictability to the complex of medication management.

Ingenious Med

Venture Round in 2015
Ingenious Med develops and delivers inpatient practice management information systems in the United States. The company's products include IM Practice Manager, an Internet-based application that enables inpatient physicians to capture charges and communicate digitally with peers and administrators; Charge Capture Tools, which help physicians to capture charges; Coding and Compliance Tools that offer billing departments with bills and enable billers to review and submit physician charges; and Communication Tools, which provide communication between physicians in practice, administrators, billers, and primary care, physicians. Its products also include Clinical Tools that provide physicians with a set of tools for e-prescribing, recording labs, and taking notes; Business Intelligence Tools, which enable physicians and administrators to measure, view, and analyze physician and practice performance data; and Back Office Tools that allows billing and coding staff to handle charges. In addition, the company provides Web-based training and implementation services. Its customers include physician groups, academic programs, healthcare systems, and management companies. Ingenious Med, Inc. has a strategic alliance with CodeCorrect, Inc. The company was founded in 1999 and is based in Atlanta, Georgia.

Ginger

Series B in 2014
Ginger is a telemental health provider delivering evidence-based behavioral health coaching, therapy, and psychiatry from a smartphone. Ginger's on-demand system brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone. The app provides members with access to the support they need within seconds, 24/7, 365 days a year. Millions of people have access to Ginger through leading employers, health plans, and its network of partners.

MetricStream

Venture Round in 2014
MetricStream is the global SaaS leader of integrated risk management and governance, risk, and compliance solutions that empower organizations to thrive on risk by accelerating growth through risk-aware decisions. They connect governance, risk management, and compliance across the extended enterprise. MetricStream apps improve business performance by strengthening risk management, corporate governance, regulatory compliance, vendor governance, and quality management for hundreds of thousands of users in dozens of industries.

Valeritas

Series D in 2014
Valeritas is a medical technology company committed to developing and commercializing innovative drug delivery solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of diabetes. Valeritas' medical technologies portfolio is headlined by the h-Patch technology. The first use of the h-Patch technology will be the V-Go disposable insulin delivery device for continuous delivery both at a preset basal rate and for on-demand bolus dosing at mealtimes. The V-Go is a simple-to-use, once-daily, disposable insulin delivery device that provides a preset basal rate and on-demand bolus dosing for mealtime coverage via a mealtime insulin. The V-Go will enable the millions suffering from Type 2 diabetes to conveniently and discreetly deliver insulin throughout the day bolus dose on-demand around mealtimes. The h-Patch technology is also being developed to serve as a launching platform for applications across a wide spectrum of medical needs.

Omada

Series B in 2014
Omada Health is a digital care company that offers innovative and clinically effective digital health programs to empower individuals to engage in their health and lead healthier lives. The program is personalized to meet each participant’s unique needs as they evolve, ranging from diabetes prevention, type 2 diabetes management, hypertension, behavioral health, and musculoskeletal issues. Omada combines professional health coaching, connected health devices, real-time data, and personalized feedback to deliver clinically meaningful results. The company is the largest CDC-recognized provider of the National Diabetes Prevention Program.

Vapotherm

Series B in 2014
Vapotherm is specializing in the development, manufacture, and marketing of respiratory devices that improve clinical outcomes, reduce overall delivery costs, and improve quality of life for patients. The company's breakthrough technology centers on the benefits of high flow delivery of breathing gases through a patented process for heating and humidification. Vapotherm high velocity therapy has been shown to provide proven, comfortable respiratory support without the use of a mask. High Velocity Therapy is a method of rethinking ventilatory support while keeping patient comfort and compliance in mind.

Transcend Medical

Series C in 2014
Transcend Medical is focused on the development of medical devices for the treatment of glaucoma, a cause of adult irreversible blindness. It is estimated that nearly four million people in the US and over 60 million worldwide are afflicted with the disease today and the numbers are expected to grow to nearly six million in the US, and to over 70 million worldwide by the year 2015. In 2005, Transcend Medical was the first company to spin out of ForSight Labs, an incubator solely focused on ophthalmic innovations. Transcend Medical was granted CE mark for the CyPass Micro-Stent® in 2008, and is being evaluated in several clinical studies in the US and abroad, including the COMPASS multi-center clinical trial.

TriVascular

Series E in 2013
TRIVASCULAR is committed to developing new medical devices that address unmet clinical needs while providing an excellent working environment for its employees. The company was founded by Michael Chobotov, Ph.D., Robert Whirley, Ph.D., and Joseph Humphrey, Ph.D. TriVascular is located 50 miles north of San Francisco in the heart of the Sonoma Wine Country. TriVascular offers excellent career opportunities, benefits and quality of life to its employees. TRIVASCULAR's first products are next-generation transluminally placed endovascular grafts, often referred to as stent-grafts, for the treatment of aneurysmal disease in the abdominal aorta (AAA) and the thoracic aorta (TAA). Such endovascular procedures can lead to substantially lower mortality, morbidity, and cost compared to open surgical repair. TriVascular has developed a novel device design that achieves a low profile, permitting substantially improved access through the vasculature.

Xanitos

Venture Round in 2013
Xanitos is a management company that provides hospital housekeeping, patient transport, and central laundries services. It is differentiated by its patent pending XRO system for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service, believing that by so doing, profits will follow. Graeme Crothall, founder and CEO, has 40 years’ experience in hospital housekeeping and during that time he has founded and led four successful companies in the industry whose revenues today exceed $2.5 billion. In 2008 Graeme founded Xanitos by acquiring two small companies, one of which owned the XRO patient room cleaning system, and continuing his track-record of providing top quality service, attracting and holding excellent operations management, and always growing the companies he leads. The results are evident; at the hospitals it serves, Xanitos has improved the cleaning quality, increased HCAHPS scores, reduced the risk of HAIs, lowered bed turn around time, and significantly reduced costs.

Movable

Seed Round in 2013
Movable offers a wrist-worn activity monitor that measures all movement. Its product MOVband is a simple and fun wrist-worn activity monitor that measures all movement, not just steps. The company’s primary targets are corporate and school-based wellness programs.

Vapotherm

Series A in 2013
Vapotherm is specializing in the development, manufacture, and marketing of respiratory devices that improve clinical outcomes, reduce overall delivery costs, and improve quality of life for patients. The company's breakthrough technology centers on the benefits of high flow delivery of breathing gases through a patented process for heating and humidification. Vapotherm high velocity therapy has been shown to provide proven, comfortable respiratory support without the use of a mask. High Velocity Therapy is a method of rethinking ventilatory support while keeping patient comfort and compliance in mind.

iRhythm Technologies

Series D in 2013
iRhythm provides innovative and cost-effective diagnostic monitoring solutions that facilitate early diagnosis and treatment decisions, with the goal of ultimately improving patient health outcomes and reducing wasteful healthcare spending. Its flagship product, the Zio® Patch, is designed to optimize and simplify the diagnosis of cardiac arrhythmias. Zio® Patch is the smallest, lightest, least conspicuous cardiac arrhythmia diagnostic available and is indicated for up to 14-day monitoring.

AtheroMed

Private Equity Round in 2013
AtheroMed, Inc. develops treatments for peripheral arterial disease. The company was incorporated in 2006 and is headquartered in Menlo Park, California.

Agile Therapeutics

Series C in 2012
Agile Therapeutics is a specialty pharmaceutical company that engages in the development of women's healthcare products. It offers a low estrogen dose seven-day transdermal contraceptive patch system that delivers a combination of levonorgestrel and ethinylestradiol. This is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women.

Oxford Immunotec

Venture Round in 2012
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Astute Medical

Series C in 2012
Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is on community and hospital-acquired acute conditions that require rapid diagnosis and risk assessment. The company's current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis. Founded in 2007, the company is led by Christopher Hibberd and Paul McPherson, former members of the management at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations in 2007 for $1.7 billion. Hibberd served at Biosite for 10 years, most recently as Senior Vice President Corporate Development. Dr. McPherson was at Biosite for 14 years, most recently as Vice President Research and Development.

GluMetrics

Venture Round in 2012
GluMetrics, Inc., a medical device company, develops tools that enable clinicians to implement a care paradigm for critically ill patients. Its products include GluCath, an intravascular continuous glucose monitoring system to measure blood sugar. The company was founded in 2005 and is based in Irvine, California.

AtheroMed

Series D in 2012
AtheroMed, Inc. develops treatments for peripheral arterial disease. The company was incorporated in 2006 and is headquartered in Menlo Park, California.

Transcend Medical

Series B in 2012
Transcend Medical is focused on the development of medical devices for the treatment of glaucoma, a cause of adult irreversible blindness. It is estimated that nearly four million people in the US and over 60 million worldwide are afflicted with the disease today and the numbers are expected to grow to nearly six million in the US, and to over 70 million worldwide by the year 2015. In 2005, Transcend Medical was the first company to spin out of ForSight Labs, an incubator solely focused on ophthalmic innovations. Transcend Medical was granted CE mark for the CyPass Micro-Stent® in 2008, and is being evaluated in several clinical studies in the US and abroad, including the COMPASS multi-center clinical trial.

iRhythm Technologies

Private Equity Round in 2012
iRhythm provides innovative and cost-effective diagnostic monitoring solutions that facilitate early diagnosis and treatment decisions, with the goal of ultimately improving patient health outcomes and reducing wasteful healthcare spending. Its flagship product, the Zio® Patch, is designed to optimize and simplify the diagnosis of cardiac arrhythmias. Zio® Patch is the smallest, lightest, least conspicuous cardiac arrhythmia diagnostic available and is indicated for up to 14-day monitoring.

Xanitos

Venture Round in 2011
Xanitos is a management company that provides hospital housekeeping, patient transport, and central laundries services. It is differentiated by its patent pending XRO system for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service, believing that by so doing, profits will follow. Graeme Crothall, founder and CEO, has 40 years’ experience in hospital housekeeping and during that time he has founded and led four successful companies in the industry whose revenues today exceed $2.5 billion. In 2008 Graeme founded Xanitos by acquiring two small companies, one of which owned the XRO patient room cleaning system, and continuing his track-record of providing top quality service, attracting and holding excellent operations management, and always growing the companies he leads. The results are evident; at the hospitals it serves, Xanitos has improved the cleaning quality, increased HCAHPS scores, reduced the risk of HAIs, lowered bed turn around time, and significantly reduced costs.

Transcend Medical

Series B in 2011
Transcend Medical is focused on the development of medical devices for the treatment of glaucoma, a cause of adult irreversible blindness. It is estimated that nearly four million people in the US and over 60 million worldwide are afflicted with the disease today and the numbers are expected to grow to nearly six million in the US, and to over 70 million worldwide by the year 2015. In 2005, Transcend Medical was the first company to spin out of ForSight Labs, an incubator solely focused on ophthalmic innovations. Transcend Medical was granted CE mark for the CyPass Micro-Stent® in 2008, and is being evaluated in several clinical studies in the US and abroad, including the COMPASS multi-center clinical trial.

Accumetrics

Venture Round in 2010
Accumetrics is a privately-held company that develops, manufactures, and markets the VerifyNow System, a comprehensive suite of assays for the assessment of platelet function. Accumetrics, based in San Diego, California, was founded in 1996, sold to Radiometer in 2000, and repurchased by company management and investors in 2003.

Baxano

Series C in 2010
Baxano, Inc. develops minimally invasive tools to restore spine function and preserve healthy tissue. The company offers iO-Flex System, which targets and decompresses bone and soft tissue in the foramen, lateral recess, and central canal for patients with single and multi-level mild, moderate, and severe stenosis. Its products comprise Neuro Check device that allows the surgeon to confirm that the device is against the bone and the nerve is safely out of the way; MicroBlade ShaverTM instrument, which is used to remove the impinging bone and ligament; Guidewire; probes; and distal handles. The company was founded in 2005 and is based in San Jose, California.

Predictive Biosciences

Series C in 2010
Predictive Biosciences, Inc., a molecular diagnostics company, develops diagnostic products for informed cancer management. It specializes in proteomics, diagnostics, oncology, and tumor biomarkers. The company offers biomarkers and proteomics-based assay technologies. These assays detect urinary biomarkers associated with the physiological changes resulting from cancer development and progression. It also provides Triage Monitoring Assay, which allows physicians to delay and invasive diagnostic procedures; Interval Monitoring Assay that is for surveillance and detection of cancer between follow-ups; and Stratification Assay, which supports a physician's decision to manage a patient. Predictive Biosciences, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.

Agile Therapeutics

Series B in 2010
Agile Therapeutics is a specialty pharmaceutical company that engages in the development of women's healthcare products. It offers a low estrogen dose seven-day transdermal contraceptive patch system that delivers a combination of levonorgestrel and ethinylestradiol. This is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women.

Oxford Immunotec

Series D in 2010
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Hemosphere

Series A in 2010
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction.

Accumetrics

Series E in 2009
Accumetrics is a privately-held company that develops, manufactures, and markets the VerifyNow System, a comprehensive suite of assays for the assessment of platelet function. Accumetrics, based in San Diego, California, was founded in 1996, sold to Radiometer in 2000, and repurchased by company management and investors in 2003.

ValenTx

Series B in 2009
ValenTx is a development-stage medical device company that focuses on minimally-invasive methods for the treatment of morbid obesity. The company was founded in 2002 and headquartered in Maple Grove, Minnesota.

Silverlink Communications

Series D in 2009
Silverlink Communications is a healthcare IT company that develops solutions for patient communications and engagement. The company provides communications services for managed care, pharmacy, population health, Medicare and Medicaid, multi-channel services, and interactive voice services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.